These results indicate that PAMAM dendrimer (G2) may possess both inhibitory and breaking effects on ATTR V30M amyloid, suggesting that PAMAM dendrimer has the potential as a dual effective agent against TTR amyloidosis [43]. Here, TTR is linked to amyloidosis.